These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 14579809)
21. In search of a compromised solution to the problem arising from patenting biomedical research tools. Derzko NM Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840 [No Abstract] [Full Text] [Related]
25. Drug patent protection: how long is long enough? Sibbald B CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146 [No Abstract] [Full Text] [Related]
26. Access to tangible research materials in biomedical research: conditions of access and their effect on research. Monotti AL J Law Med; 2006 Aug; 14(1):86-101. PubMed ID: 16937783 [TBL] [Abstract][Full Text] [Related]
27. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
28. Patent reform in the US: what's at stake for pharmaceutical innovation? Yancey A; Stewart CN Expert Opin Ther Pat; 2010 May; 20(5):603-8. PubMed ID: 20402544 [TBL] [Abstract][Full Text] [Related]
29. HIV drugs. New Congress could create hurdles for drug patents. AIDS Policy Law; 2007 Jan; 22(2):5. PubMed ID: 17319014 [No Abstract] [Full Text] [Related]
30. Your money or your life. Westphal SP New Sci; 2002 Jul; 175(2351):28-33. PubMed ID: 12625339 [No Abstract] [Full Text] [Related]
31. A guide to drug discovery. Protecting your inventions: the patent system. Webber PM Nat Rev Drug Discov; 2003 Oct; 2(10):823-30. PubMed ID: 14526385 [TBL] [Abstract][Full Text] [Related]
32. Generics battle brand names over mortality of drug patents. Betz R J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008 [No Abstract] [Full Text] [Related]
33. Taking the profit out of biomedical research tools. Flores MA Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252 [TBL] [Abstract][Full Text] [Related]
37. Patents: a threat to innovation? Manocaran M Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557 [No Abstract] [Full Text] [Related]
38. Much ado about gene patents: the role of foreseeability. Gulliford MJ Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032 [No Abstract] [Full Text] [Related]
39. Reach-through claims for drug target patents: Rx for pharmaceutical policy. Bohrer RA Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015 [No Abstract] [Full Text] [Related]
40. Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals. Manthei JR; Hathaway CR; Grant MA; Chung DD Food Drug Law J; 2006; 61(2):273-7. PubMed ID: 16903032 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]